My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Livewire Live
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Livewire Live
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
osprey medical
Latest news and analysis on osprey medical
May 23, 2017 09:12
Executive Series - Osprey Medical (OSP) CEO, Mike
McCormick
OSP
OSPREY MEDICAL INC
ASX:OSP
Followed by
10
people
OSP
OSPREY MEDICAL INC
ASX:OSP
Followed by
10
people
CommSec
Online Stockbroker
May 23, 2017 09:12
July 26, 2016 09:29
Executive Series - Osprey Medical (OSP) CEO, Mike
McCormick
CommSec
Online Stockbroker
July 26, 2016 09:29
July 14, 2015 13:56
Medtech Companies Gained 45.6% in FY15, And A Strong FY16 Expected
Canaccord Genuity
Stockbroker
July 14, 2015 13:56
Advertisement
December 06, 2013 13:56
Cannacord rates Osprey Medical (OSP) a buy with a price target of $1.25 from the current price of around
$.69
Livewire Exclusive
Livewire Markets
December 06, 2013 13:56
4
most
popular
Reporting Season
Wild swings, big opportunities: 6 ASX best ideas Morgans is backing
Vishal Teckchandani,
Livewire Markets
Equities
Is 4D Medical the real deal? CEO Dr Andreas Fouras makes his
case
Chris Conway,
Livewire Markets
Buy Hold Sell
Buy Hold Sell: 6 ASX large cap leaders and
laggards
Tom Stelzer,
Livewire Markets
Equities
Five boring ASX stocks the market may be overlooking
Ryan Lim,
Alpha Insights
view all
Advertisement
